Deficient Pseudomonas aeruginosa in MlaA/VacJ outer membrane lipoprotein shows decrease in rhamnolipids secretion, motility, and biofilm formation, and increase in fluoroquinolones susceptibility and innate immune response

Res Microbiol. 2023 Nov-Dec;174(8):104132. doi: 10.1016/j.resmic.2023.104132. Epub 2023 Sep 1.

Abstract

Pseudomonas aeruginosa, a Gram-negative bacterium that causes severe hospital acquired infections poses threat by its ability for adaptation to various growth modes and environmental conditions and by its intrinsic resistance to antibiotics. The latter is mainly due to the outer membrane (OM) asymmetry which is maintained by the Mla pathway resulting in the retrograde transport of glycerophospholipids from the OM to the inner membrane. It comprises six Mla proteins, including MlaA, an OM lipoprotein involved in the removal of glycerophospholipids mislocalized at the outer leaflet of OM. To investigate the role of P. aeruginosa OM asymmetry especially MlaA, this study investigated the effect of mlaA deletion on (i) the susceptibility to antibiotics, (ii) the secretion of virulence factors, the motility, biofilm formation, and (iii) the inflammatory response. mlaA deletion in P. aeruginosa ATCC27853 results in phenotypic changes including, an increase in fluoroquinolones susceptibility and in PQS (Pseudomonas Quinolone Signal) and TNF-α release and a decrease in rhamnolipids secretion, motility and biofilm formation. Investigating how the mlaA knockout impacts on antibiotic susceptibility, bacterial virulence and innate immune response will help to elucidate the biological significance of the Mla system and contribute to the understanding of MlaA in P. aeruginosa OM asymmetry.

Keywords: Amphiphilic aminoglycoside antibiotic; Biofilm; Mla system; MlaA; Outer membrane asymmetry; Pseudomonas aeruginosa.

MeSH terms

  • Anti-Bacterial Agents / metabolism
  • Anti-Bacterial Agents / pharmacology
  • Bacterial Outer Membrane Proteins* / genetics
  • Bacterial Outer Membrane Proteins* / metabolism
  • Biofilms
  • Fluoroquinolones / pharmacology
  • Glycerophospholipids / metabolism
  • Immunity, Innate
  • Lipoproteins / genetics
  • Lipoproteins / metabolism
  • Pseudomonas aeruginosa* / metabolism

Substances

  • rhamnolipid
  • Bacterial Outer Membrane Proteins
  • Fluoroquinolones
  • Anti-Bacterial Agents
  • Lipoproteins
  • Glycerophospholipids